In Every Region of the U.S., Mothers are Living In Maternal Red Flag Zones: New Data Maps Communities Where Risks are Highest

Read original · https://www.prnewswire.com/news-releases/in-every-region-of-the-us-mothers-are-living-in-maternal-red-flag-zones-new-data-maps-communities-where-risks-are-highest-302789381.html

Search tags

What matters in this story

Medicaid cuts are leading to the closure of rural maternity wards across the United States. — Closure of healthcare facilities reduces service availability and revenue for healthcare providers in rural markets.

-0.40

The Trump Administration has paused data collection for a critical federal maternal health surveillance program. — Loss of federal health surveillance data can lead to inefficient resource allocation and delayed responses to public health crises.

-0.30

Surgo Health has released a new Maternal Vulnerability Index (MVI) to map pregnancy-related risks down to the zip code level. — Provides a new tool for targeted healthcare interventions and private sector health resource planning.

+0.10

In Every Region of the U.S., Mothers are Living In Maternal Red Flag Zones: New Data Maps Communities Where Risks are Highest

What matters in this story

Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript

In Every Region of the U.S., Mothers are Living In Maternal Red Flag Zones: New Data Maps Communities Where Risks are Highest

What matters in this story

Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Investors bet humanoid robots will transform industry and homes over the next decade

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren's Disease at EULAR 2026

US Proposes Tariffs Over Alleged Forced Labor. Here's How Pompeo, Markets Reacted.

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

In Every Region of the U.S., Mothers are Living In Maternal Red Flag Zones: New Data Maps Communities Where Risks are Highest

What matters in this story

Next reads from the same story arc

Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript

In Every Region of the U.S., Mothers are Living In Maternal Red Flag Zones: New Data Maps Communities Where Risks are Highest

What matters in this story

Next reads from the same story arc

Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Investors bet humanoid robots will transform industry and homes over the next decade

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren's Disease at EULAR 2026

US Proposes Tariffs Over Alleged Forced Labor. Here's How Pompeo, Markets Reacted.

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study